60 Recruiting Breast Cancer Phase 1 Clinical Trials
Active phase 1 studies for breast cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Breast Cancer studiesPhase 1 Studies for Breast Cancer
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
📍 UCLA Jonsson Comp Cancer Center — Los Angeles, California
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)
📍 Stanford Women's Cancer Center — Palo Alto, California
View Study & Checklist ➔CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
📍 BCCA - Vancouver Cancer Centre — Vancouver, British Columbia
View Study & Checklist ➔To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
📍 Massachusetts General Hospital. — Boston, Massachusetts
View Study & Checklist ➔Breast Cancer Study of Preoperative Pembrolizumab + Radiation
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔'ADVANCE' (A Pilot Trial)
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
📍 University of Pennsylvania Hospital — Philadelphia, Pennsylvania
View Study & Checklist ➔Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
📍 Univ of California at San Diego Moores Cancer Ctr — San Diego, California
View Study & Checklist ➔P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
📍 University of California, Irvine Medical Center — Irvine, California
View Study & Checklist ➔Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
📍 Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
📍 Highlands Oncology Group — Fayetteville, Arkansas
View Study & Checklist ➔Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
📍 Dothan Hematology and Oncology — Dothan, Alabama
View Study & Checklist ➔Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer
📍 University of Texas Southwestern Medical Center - Dallas — Dallas, Texas
View Study & Checklist ➔Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
📍 Site 08 — Denver, Colorado
View Study & Checklist ➔A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
📍 Highlands Oncology — Fayetteville, Arkansas
View Study & Checklist ➔Focused Ultrasound and Gemcitabine in Breast Cancer
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer
📍 Providence Portland Medical Center — Portland, Oregon
View Study & Checklist ➔Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
📍 Hoag Memorial Presbyterian — Newport Beach, California
View Study & Checklist ➔BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy
📍 Perelman Center for Advanced Medicine — Philadelphia, Pennsylvania
View Study & Checklist ➔Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
📍 The University of Kansas Clinical Research Center — Fairway, Kansas
View Study & Checklist ➔Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
📍 Administrative Address: UCLA Hematology/Oncology — Los Angeles, California
View Study & Checklist ➔Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔T-Cell Therapy for Advanced Breast Cancer
📍 Memorial Sloan Kettering Cancer Center (Consent and follow-up only) — Basking Ridge, New Jersey
View Study & Checklist ➔TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
📍 MedStar Georgetown University Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
📍 Stanford Women's Cancer Center — Palo Alto, California
View Study & Checklist ➔Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations
📍 New York Presbyterian Hospital - Queens — New York, New York
View Study & Checklist ➔A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
📍 University of Colorado — Aurora, Colorado
View Study & Checklist ➔DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
📍 Univ. of Cali. San Francisco Medical Center — San Francisco, California
View Study & Checklist ➔Onvansertib + Paclitaxel In TNBC
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
View Study & Checklist ➔A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
📍 UCLA Medical Center — Los Angeles, California
View Study & Checklist ➔FMT in Triple Negative Breast Cancer Guided by ctDNA
📍 London Health Sciences Center — London, Ontario
View Study & Checklist ➔Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
📍 Miami Cancer Institute at Baptist Health, Inc. — Miami, Florida
View Study & Checklist ➔TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers
📍 UT MD Anderson — Houston, Texas
View Study & Checklist ➔Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
📍 Florida Cancer Specialists — Orlando, Florida
View Study & Checklist ➔Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
📍 Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
📍 Mayo Clinic of Scottsdale — Scottsdale, Arizona
View Study & Checklist ➔Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
📍 Stony Brook Breast Center — Stony Brook, New York
View Study & Checklist ➔CBD for Breast Cancer Primary Tumors
📍 Medical University of South Carolina — Charleston, South Carolina
View Study & Checklist ➔Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
📍 Stephenson Cancer Center — Oklahoma City, Oklahoma
View Study & Checklist ➔[18F] F-GLN by PET/CT in Breast Cancer
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔VS-6766+Abema+Fulv in Met HR+/HER- BC
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
📍 Sarcoma Oncology Center — Santa Monica, California
View Study & Checklist ➔HER2 Vaccine for Locally Advanced Breast Cancer
📍 Indiana University Melvin & Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana
View Study & Checklist ➔RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
📍 RWJBarnabas Health Clara Maas Medical Center — Belleville, New Jersey
View Study & Checklist ➔Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
📍 Baylor University Medical Center, Baylor Charles A Sammons Cancer Center — Dallas, Texas
View Study & Checklist ➔